Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
Manal Rayyan, Adjunct Assistant Professor at United Arab Emirates University, Senior Clinical Pharmacist at SEHA Tawam Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
“I’m pleased to share our latest publication:
‘Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with haemophilia A: A single-centre experience from the UAE.’
Conducted at Tawam Hospital, this study shows excellent real-world outcomes after switching to once-weekly efanesoctocog alfa prophylaxis, with all patients achieving zero annualized bleeding rate (ABR) and demonstrating a strong safety profile.
I’m grateful to my co-authors and colleagues for their collaboration and commitment to improving care for children with bleeding disorders.
Congratulations to the entire team!”
Title: Real-world treatment patterns and outcomes of switching to efanesoctocog alfa in children with severe and moderate haemophilia a: A single-centre experience from the United Arab Emirates
Authors: Muhammad Faisal Khanani, Najam Awan, Haydar Alrufaey, Manal Ryan

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 28, 2026, 15:00Rucha Patil: Grateful to Contribute to the National Coagulation Conclave 2026
-
Jul 28, 2026, 14:51Islam Aboumoussa: A New Perspective on Dual Antithrombotic Therapy in Stroke Prevention
-
Jul 28, 2026, 14:40Marilena Vrana: Join the Conversation at Plasma Protein Forum 2026
-
Jul 28, 2026, 14:24Jon Wright: Pushing the Boundaries of Hemophilia Care
-
Jul 28, 2026, 14:11Improving Care for People with Bleeding Disorders Through Teamwork – WFH
-
Jul 28, 2026, 14:10Blessing Oluwasanya: When Heavy Periods Are More Than Just an Inconvenience
-
Jul 28, 2026, 13:22Raelene Kambli: Advocating for Safer Blood Access
-
Jul 28, 2026, 13:07Connie Montgomery: Conversations That Change Hemophilia Care
-
Jul 28, 2026, 09:06Payal Desai: Highlights from the NASCC 2026 Sickle Cell Workshop